Douglas Miehm
Stock Analyst at RBC Capital
(0)
# 4347
Out of 5,291 analysts
5
Total ratings
0.00%
Success rate
-12.30%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Oncolytics Biotech | Maintains: Outperform | 6 5 | 0.6 | 733.33% | 1 | Mar 10, 2025 | |
Bausch & Lomb | Maintains: Outperform | 22 18 | 14.18 | 26.94% | 2 | Feb 20, 2025 | |
Bausch Health Compan... | Maintains: Sector Perform | 11 10 | 6.49 | 54.08% | 1 | Jan 30, 2025 | |
Ligand Pharmaceutica... | Maintains: Outperform | 141 143 | 107.44 | 33.1% | 1 | Dec 11, 2024 |